For a selection of antihypertensive drugs for hypertensive patients with diabetes, renin-angiotensin (RA) system inhibitors (angiotensin-converting enzyme [ACE] inhibitor and angiotensin receptor blocker [ARB]) are recommended as first-line therapy in consideration of effects on glucose/lipid metabolism as well as prevention of complications. Here, ACE is linked to diabetes mellitus.